- Home
- NEXT vs ZLAB Comparison
NEXT vs ZLAB Comparison
Compare NEXT & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEXT
- ZLAB
- Stock Information
- Founded
- NEXT 2010
- ZLAB 2013
- Country
- NEXT United States
- ZLAB China
- Employees
- NEXT N/A
- ZLAB N/A
- Industry
- NEXT Oil & Gas Production
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- NEXT Energy
- ZLAB Health Care
- Exchange
- NEXT Nasdaq
- ZLAB Nasdaq
- Market Cap
- NEXT 2.0B
- ZLAB 3.6B
- IPO Year
- NEXT N/A
- ZLAB 2017
- Fundamental
- Price
- NEXT $9.14
- ZLAB $36.40
- Analyst Decision
- NEXT
- ZLAB Buy
- Analyst Count
- NEXT 0
- ZLAB 5
- Target Price
- NEXT N/A
- ZLAB $54.28
- AVG Volume (30 Days)
- NEXT 2.6M
- ZLAB 886.5K
- Earning Date
- NEXT 08-13-2025
- ZLAB 08-05-2025
- Dividend Yield
- NEXT N/A
- ZLAB N/A
- EPS Growth
- NEXT N/A
- ZLAB N/A
- EPS
- NEXT N/A
- ZLAB N/A
- Revenue
- NEXT N/A
- ZLAB $418,326,000.00
- Revenue This Year
- NEXT N/A
- ZLAB $44.07
- Revenue Next Year
- NEXT N/A
- ZLAB $49.13
- P/E Ratio
- NEXT N/A
- ZLAB N/A
- Revenue Growth
- NEXT N/A
- ZLAB 43.72
- 52 Week Low
- NEXT $4.27
- ZLAB $16.01
- 52 Week High
- NEXT $9.71
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- NEXT 61.70
- ZLAB 52.67
- Support Level
- NEXT $8.57
- ZLAB $34.79
- Resistance Level
- NEXT $9.04
- ZLAB $36.73
- Average True Range (ATR)
- NEXT 0.40
- ZLAB 1.23
- MACD
- NEXT 0.03
- ZLAB -0.46
- Stochastic Oscillator
- NEXT 78.93
- ZLAB 25.91
About NEXT NextDecade Corporation
NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas and sale of LNG and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.